Reference List 1
Antonuccio, D. O., Burns, D. D., Danton, W. G.,
& O’Donohue, W. T. (2000, October, 27). The
psychological perspective on depression. Lecture
presented at 13th Annual Paul McReynolds Lecture
and Workshop Series, University of Nevada at
Reno.
Antonuccio, D. O., Danton, W. G., DeNelsky, G.
Y., Greenberg, R. P., & Gordon, J. S. (1999)
Raising questions about antidepressants.
Psychotherapy and Psychosomatics, 68(3), 31-14.
Arakawa, O. (1994). Effects of methamphetamine
and methylphenidate on single and paired rat
open-field behaviors. Physiology and Behavior,
55, 441-446.
Baker, J. P. (1984). Outcomes of lithium
discontinuation: A meta-analysis. Lithium, 5,
187-192.
Baldessarini, R. J., & Viguera, A. C. (1995).
Neuroleptic withdrawal in schizophrenic
patients. Archives of General Psychiatry, 52,
189-192.
Baldessarini, R.J., & Tondo, L. (1997). Effects
of lithium treatment and its discontinuation in
bipolar disorders. American Society of Clinical
Psychopharmacological Progress Notes, 8(2),
21-26.
Bell, R. D., Alexander, G. M., Schwartzman, R.
J., & Yu, J. (1982). The methylphenidate-induced
stereotypy in the awake rate: Local cerebral
metabolism. Neurology, 32, 377-381.
Bhattacharyya, A. K., Ghosh, B., Aulakh, C. S.,
& Pradhan, S. N. (1980). Correlation of
behavioral and neurochemical effects of acute
administration of methylphedidate in rats.
Progress in Neuro-Psychopharmacology, 4,
129-136.
Bockoven, J. S. (1956). Moral treatment in
American psychiatry. The Journal of Nervous and
Mental Disease, 124 (2 & 3), 167-194 & 292-321.
Boyle, M. (1990). Schizophrenia: a scientific
delusion? New York: Routledge.
Breggin, P. R. (1997). Brain disabling
treatments in psychiatry. New York: Springer.
Breggin, P. R., & Breggin, G. R. (1994). Talking
back to Prozac. New York: St. Martin’s.
Ciompi, L., Dauwalder, H.-P., Maier, C., Aebi,
E., Trütsch, K., Kupper, Z., & Rutishauer, C.
(1992). The pilot project ‘Soteria Berne’:
Clinical experiences and results. British
Journal of Psychiatry, 161(Suppl. 18), 145-153.
Cohen, D. (1997). A critique of the use of
neuroleptic drugs in psychiatry. In S. Fisher &
R. Greenberg (Eds.), From placebo to panacea
(pp. 173-228). New York: Wiley.
Colbert, T. C. (2001). Rape of the Soul. Tustin,
CA: Kevco.
DeLisi, L. E., Shaw, S. H., Crow, T. J., &
Shields, et al. (2002). American Journal of
Psychiatry, 159 (5), pp.803-
Fergusson, A. (2000). Accompanied autoanalysis:
An empathic approach to helping deeply disturbed
persons. Ethical Human Sciences and Services: An
International Journal of Critical Inquiry, 2, 1,
9-20.
Greenberg, R. P. & Fisher, S. (1997).
Mood-mending medicines: Probing drug,
psychotherapy, and placebo solutions. In S.
Fisher and R. Greenberg (Eds.), From placebo to
panacea (pp. 115-172). New York: Wiley.
Hegarty, J., Baldessarini, R. J., Tohen, M.,
Waternaux, C., & Oepen, G. (1994). One hundred
years of schizophrenia: A meta-analysis of the
outcome literature. American Journal of
Psychiatry, 151, 1409-1416.
Hotz, R. L. (2002, February, 18). Healing body
by fakery. Los Angeles Times, p. A-14.
Healey, D. (1997). The Antidepressant Era.
Cambridge, MA: Harvard University Press.
Healey, D. (2002). The Creation of
Psychopharmacology. Cambridge, MA: Harvard
University Press.
Joseph, J. (1998). A critical analysis of the
genetic theory of schizophrenia. Unpublished
doctoral dissertation, California School of
Professional Psychology, Alameda.
Karon, B. (1999). The tragedy of schizophrenia.
The General Psychologist, 32(1), 3-14.
Keefe, R. S., & Harvey, P. D. (1994).
Understanding schizophrenia. New York: The Free
Press.
Kety, S., Rosenthal, D., Wender, P., &
Schulsinger, F. (1968). The types and prevalence
of mental illness in the biological and adoptive
families of adopted schizophrenics. In D.
Rosenthal & S. Kety (Eds.), The transmission of
schizophrenia (pp. 345-362). New York: Pergamon.
Khan, A. U. (1999, October). How do psychotropic
medications really work? Psychiatric Times, XVI
(10), 11.
Kirsch, I, & Sapirstein, G. (1999). Listening to
Prozac, but hearing placebo? A meta-analysis of
antidepressant medication. In I. Kirsch (Ed.),
How expectations shape experience (pp. 303-320).
New York: American Psychiatric Press.
Kissling, W. (1992). Ideal and reality of
neuroleptic relapse prevention. British Journal
of Psychiatry, 161, 133-139.
Lewontin, R., Rose, S., & Kamin, L. (1984). Not
in our genes. New York: Pantheon.
Matthews, S. M., Roper, M. T., Mosher, L. R., &
Menn, A. Z. (1979). A non-neuroleptic treatment
for schizophrenia: Analysis of the two-year
postdischarge risk for relapse. Schizophrenia
Bulletin, 5, 322-333.
Moore, T. J. (1997, December). Hard to swallow.
The Washingtonian, pp.68-71 & 140-145.
Moore, T. (1998). Prescription for disaster. New
York: Simon & Schuster.
Mosher, L., & Menn, A. Z. (1978). Community
residential treatment for schizophrenia:
Two-year follow-up. Hospital and Community
Psychiatry, 29, 715-723.
Mosher, R. L. (1995). The Soteria project: The
first generation American alternative to
psychiatric hospitalization. In R. Warner (Ed.),
Alternatives to the hospital for acute
psychiatric treatment (pp. 111-129). Washington,
DC: American Psychiatric Press, Inc.
Ross, C. A. (1995). Errors of logic in
biological psychiatry. In C. A. Ross & A. Pam,
Pseudoscience in biological psychiatry, pp.
85-128. New York: John Wiley.
Rumble in Reno. (2000, October, 27). The causes,
treatment, politics, and ethics of depression.
Lectures presented at 13th Annual Paul
McReynolds Lecture and Workshop Series,
University of Nevada at Reno.
Stein, D. (2001). Unraveling the Add/Adhd
fiasco. Andrews McMeel Publishing
Stein, D. (2002). Ritalin is not the answer
action guide: An interactive companion to the
best selling drug-fee Add/Adhd parenting
program. Jossey-Bass Publishing.
Wang, G-J., Volkow, N., Fowler, J., Ferrieri,
R., Schlyer, D., Alexoff, D., Pappas, N.,
Lieberman, J., King, P., Warner, D., Wong, C.,
Hitzemann, R., & Wolf, A. (1994).
Methylphenidate decreases regional cerebral
blood flow in normal human subjects. Life
Sciences, 54, 143-146.
Whitaker, R. (2002). Mad in America. Cambridge,
MA: Perseus. |
